Pneumonic Plague

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-10-06
Clinical Trial Update: Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age [Phase 2]
Phase 2 clinical trial evaluating the immunogenicity, safety, and tolerability of the rF1V-1018 vaccine in adults 18-55 for pneumonic plague…